Evidence map›Paper›PMID 33359064›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.

Stefania Paolucci, Irene Cassaniti, Federica Novazzi, Loretta Fiorina, Antonio Piralla, Giuditta Comolli, Raffaele Bruno, Renato Maserati, Roberto Gulminetti, Stefano Novati and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Stefania PaolucciMolecular Virology Unit, Microbiology and VirologyDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Irene CassanitiMolecular Virology Unit, Microbiology and VirologyDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Federica NovazziMolecular Virology Unit, Microbiology and VirologyDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Loretta FiorinaLaboratorio Genetica - Trapiantologia e Malattie Cardiovascolari, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Antonio PirallaMolecular Virology Unit, Microbiology and VirologyDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Giuditta ComolliMolecular Virology Unit, Microbiology and VirologyDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Experimental ResearchLaboratories, Biotechnology Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Raffaele BrunoInfectious DiseaseDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Renato MaseratiInfectious DiseaseDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Roberto GulminettiInfectious DiseaseDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Stefano NovatiInfectious DiseaseDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Francesco MojoliAnesthesia and Intensive Care, Emergency Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Fausto BaldantiMolecular Virology Unit, Microbiology and VirologyDepartment, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy. Electronic address: f.baldanti@smatteo.pv.it.
San Matteo Pavia COVID-19 Task Force
University of Pavia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe immunologic profile and opportunistic viral DNA increase were monitored in Italian patients with COVID-19 in order to identify markers of disease severity.

methodsA total of 104 patients infected with SARS-CoV-2 were evaluated in the study. Of them, 42/104 (40.4%) were hospitalized in an intensive care unit (ICU) and 62/104(59.6%) in a sub-intensive care unit (SICU). Human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV), Parvovirus B19 and Human Herpesvirus 6 virus reactivations were determined by real-time PCR, and lymphocyte subpopulation counts were determined by flow cytometry.

resultsAmong opportunistic viruses, only EBV was consistently detected. EBV DNA was observed in 40/42 (95.2%) of the ICU patients and in 51/61 (83.6%) of the SICU patients. Comparing the two groups of patients, the EBV DNA median level among ICU patients was significantly higher than that observed in SICU patients. In parallel, a significant reduction of CD8 T cell and NK count in ICU patients as compared with SICU patients was observed (p<0.05). In contrast, B cell count was significantly increased in ICU patients (p=0.0172).

conclusionsA correlation between reduced CD8

Indexed as

SARS-CoV-2Viral LoadAgedAged, 80 and overCD8-Positive T-LymphocytesCOVID-19DNA, ViralEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHumansIntensive Care UnitsKiller Cells, NaturalLymphocyte CountLymphocyte SubsetsMaleDNA, ViralCOVID-19EBV DNALymphocyte subpopulation

Identifiers

PMID33359064
PMCPMC7833117
OpenAlexW3117629629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.